Due to the lapse in appropriations, Department of Justice websites will not be regularly updated. The Department’s essential law enforcement and national security functions will continue. Please refer to the Department of Justice’s contingency plan for more information.

You are here

Justice News

Department of Justice
U.S. Attorney’s Office
District of Idaho

FOR IMMEDIATE RELEASE
Tuesday, December 12, 2017

Caldwell Woman Pleads Guilty to Obtaining Controlled Substances by Fraud

BOISE – Carrie Lynn Johnson, 42, pleaded guilty yesterday to obtaining controlled substances by fraud, U.S. Attorney Bart M. Davis announced.  A Boise federal grand jury indicted Johnson on September 14, 2017.

 

According to the plea agreement, Johnson worked as a medical assistant in a medical office from approximately January to December, 2016.  While she was employed at the medical office, she took possession of, and filled out, blank prescriptions from two practitioners.  Using the stolen prescriptions, she not only forged prescriptions to herself but also used her spouse’s name, her children’s names, and others.  Johnson took the prescriptions to pharmacies in Canyon County and filled them for herself.  The forged prescriptions were mainly for Schedule II controlled substances.  For example, on May 23, 2016, Johnson filled a forged prescription for 150 tablets of oxycodone 30 mg and on January 11, 2017, she filled a forged prescription for 150 tablets of hydrocodone/APAP 10/325 mg. Johnson later worked at another medical office in Payette, Idaho, where she called-in an unauthorized prescription.

 

The charge of obtaining controlled substances by fraud is punishable by up to four years in prison, a maximum fine of $250,000, and up to one year of supervised release.

 

Sentencing is set for February 28, 2017, in front of Chief U.S. District Judge B. Lynn Winmill at the federal courthouse in Boise. 

 

The case was investigated by the Nampa Police Department with assistance from the Drug Enforcement Administration.

Topic(s): 
Prescription Drugs
Component(s): 
Contact: 
Barbara Layman Public Information Officer (208) 334-1211 barbara.layman@usdoj.gov
Updated December 12, 2017